http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004074444-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edeece0b45b685cc954c678683e09708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2cfd0a7a7412adb2ba8c80249a2f1ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c81ca0d84b5275d01aaa88b76f1064a0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-41
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-02
filingDate 2004-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca773e0add51594a446a340f3c581bcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_784eca74f4535aded4fb80356454bc96
publicationDate 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004074444-A3
titleOfInvention Ferric organic compounds, uses thereof and methods of making same
abstract The present invention is directed to forms of ferric organic compounds, uses thereof, and methods of making same. The present invention discloses a novel physical form of ferric citrate with dissolution properties desirable for use in medicine, including the treatment of hyperphosphatemia and metabolic acidosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8901349-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846976-B2
priorityDate 2003-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5733706-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3591616-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4180567-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447577030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22178220

Total number of triples: 35.